{"bill":{"bill_id":1697174,"change_hash":"d1beaad0e5621695949e41638465b7f5","session_id":2006,"session":{"session_id":2006,"state_id":20,"year_start":2023,"year_end":2023,"prefile":0,"sine_die":0,"prior":0,"special":0,"session_tag":"Regular Session","session_title":"2023 Regular Session","session_name":"2023 Regular Session"},"url":"https:\/\/legiscan.com\/MD\/bill\/SB575\/2023","state_link":"https:\/\/mgaleg.maryland.gov\/mgawebsite\/Legislation\/Details\/SB0575?ys=2023RS","completed":0,"status":1,"status_date":"2023-02-06","progress":[{"date":"2023-02-06","event":1},{"date":"2023-02-06","event":9}],"state":"MD","state_id":20,"bill_number":"SB575","bill_type":"B","bill_type_id":"1","body":"S","body_id":50,"current_body":"S","current_body_id":50,"title":"Drug Manufacturers - Drug Take-Back Programs (Take It Back Maryland Act)","description":"Requiring manufacturers of certain drugs to operate a certain drug take-back program or enter into a certain agreement with a drug take-back organization or the Maryland Department of Health, in conjunction with the Department of the Environment; requiring the Maryland Department of Health, in conjunction with the Department of the Environment, to determine whether a drug take-back program complies with certain requirements and to provide notification of its determination within a certain time period; etc.","pending_committee_id":1932,"committee":{"committee_id":1932,"chamber":"S","chamber_id":50,"name":"Finance"},"referrals":[{"date":"2023-02-06","committee_id":1932,"chamber":"S","chamber_id":50,"name":"Finance"}],"history":[{"date":"2023-02-06","action":"First Reading Finance","chamber":"S","chamber_id":50,"importance":1},{"date":"2023-02-07","action":"Hearing 3\/15 at 1:00 p.m.","chamber":"S","chamber_id":50,"importance":0}],"sponsors":[{"people_id":17248,"person_hash":"b5pfdzzm","party_id":"1","state_id":20,"party":"D","role_id":2,"role":"Sen","name":"Karen Lewis Young","first_name":"Karen","middle_name":"","last_name":"Lewis Young","suffix":"","nickname":"","district":"SD-003","ftm_eid":21265676,"votesmart_id":122628,"opensecrets_id":"","knowwho_pid":497685,"ballotpedia":"Karen_Lewis_Young","bioguide_id":"","sponsor_type_id":1,"sponsor_order":1,"committee_sponsor":0,"committee_id":0,"state_federal":0}],"sasts":[{"type_id":5,"type":"Crossfiled","sast_bill_number":"HB517","sast_bill_id":1689408}],"subjects":[{"subject_id":22396,"subject_name":"Public Health"},{"subject_id":3529,"subject_name":"Controlled Dangerous Substances"},{"subject_id":3182,"subject_name":"Drugs"},{"subject_id":318538,"subject_name":"Environment, Department of the"},{"subject_id":3277,"subject_name":"Health"},{"subject_id":255963,"subject_name":"Health, Department of"},{"subject_id":3626,"subject_name":"Industry and Technology"},{"subject_id":3147,"subject_name":"Notices"},{"subject_id":3228,"subject_name":"Public Information"},{"subject_id":3162,"subject_name":"Reports"}],"texts":[{"doc_id":2685132,"date":"2023-02-07","type":"Introduced","type_id":1,"mime":"application\/pdf","mime_id":2,"url":"https:\/\/legiscan.com\/MD\/text\/SB575\/id\/2685132","state_link":"https:\/\/mgaleg.maryland.gov\/2023RS\/bills\/sb\/sb0575f.pdf","text_size":119840,"text_hash":"18c4c8048de92fef32b13d6d988a9a16"}],"votes":[],"amendments":[],"supplements":[],"calendar":[{"type_id":1,"type":"Hearing","date":"2023-03-15","time":"13:00","location":"","description":"Senate Finance Hearing"}]}}